BARBARA AGUILAR: Open Payments
NPI 1346022241 · VESTAVIA HILLS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,204 in 48 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,683 · 2025 $1,204
Food & beverage: $1,092Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $320 |
| Otsuka America Pharmaceutical, Inc. | 7 | $150 |
| Alkermes, Inc. | 10 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $140 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| ABBVIE INC. | 5 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
Products named: ARISTADA, CAPLYTA, AUSTEDO XR, INGREZZA, REXULTI, UZEDY, VRAYLAR, FANAPT.
Industry payments across AL — which companies pay providers there.
